|
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry |
May 2020 |
Annals of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro |
May 2020 |
Experimental Hematology |
Myelodysplastic Syndromes (MDS) |
|
Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia |
May 2020 |
Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation |
Aplastic Anemia |
|
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? |
May 2020 |
Best practice & research. Clinical haematology |
Myelodysplastic Syndromes (MDS) |
|
SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM) |
Apr 2020 |
Blood |
Myelodysplastic Syndromes (MDS) |
|
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of |
Apr 2020 |
Bone Marrow Transplantation |
Aplastic Anemia |
|
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide |
Apr 2020 |
Blood Advances |
Aplastic Anemia |
|
Rewriting the rules for care of MDS and AML patients in the time of COVID-19 |
Apr 2020 |
Leukemia Research Reports |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
|
Alcohol use is not a significant contributor to myelodysplastic syndromes |
Apr 2020 |
Cancer Causes & Control : CCC |
Myelodysplastic Syndromes (MDS) |
|
Evolving therapies for lower-risk myelodysplastic syndromes |
Apr 2020 |
Annals of Hematology |
Myelodysplastic Syndromes (MDS) |
